Fluvastatin Sodium Tablet, Extended Release
Brand names: Fluvastatin Sodium Er, Lescol Xl
Category: Cardiovascular
FDA status: To Be Discontinued · Last FDA update: Jan 27, 2026 · First posted: Jan 27, 2026 · 1 manufacturers, 3 listed presentations
As of Jan 27, 2026, the FDA lists Fluvastatin Sodium Tablet, Extended Release as being discontinued. Of 3 manufacturer presentations, 3 Not specified.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Fluvastatin Sodium, Tablet, Extended Release, 80 mg (NDC 0781-8017-31) NDC 0781-8017-31 |
Sandoz Inc. | Not specified | Discontinuation of the manufacture of the drug |
| Fluvastatin Sodium, Tablet, Extended Release, 80 mg (NDC 0781-8017-01) NDC 0781-8017-01 |
Sandoz Inc. | Not specified | Discontinuation of the manufacture of the drug |
| Lescol XL, Tablet, Extended Release, 80 mg (NDC 66758-211-31) NDC 66758-211-31 |
Sandoz Inc. | Not specified | Discontinuation of the manufacture of the drug |
Related medications in shortage
Other Cardiovascular medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Fluvastatin Sodium Tablet, Extended Release (FDA data as of Jan 27, 2026). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Fluvastatin Sodium Tablet, Extended Release. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/fluvastatin-sodium-tablet-extended-release.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).